480-567-1629 Call Us
Newton's First Law of Motion
Whether it’s walking 18 holes, chasing down a drop shot, or finishing a long hike, your body takes on more stress with age. Stiff joints, inflammation, and slower recovery can start to limit the activities you love.
Modern regenerative medicine—like Mesenchymal Stem Cell (MSC) therapy—is changing how we approach aging, recovery, and performance.


MSC (Mesenchymal Stem Cell) therapy uses specialized cells that help regulate healing and repair processes in the body.
These cells are known for their ability to:
Unlike traditional treatments that focus on symptoms, MSC therapy aims to support your body’s natural repair systems.
1. Joint Comfort and Mobility
2. Faster Recovery
3. Reduced Inflammation
4. Improved Quality of Life
Our MSC therapy is made possible through our partnership with TriCelX, a leader in science-based, ethically-sourced stem cells. Their mission statement is "...to improve quality of life and change the face of healthcare by challenging conventional limits as we deliver — in approved jurisdictions — evidence-based, minimally invasive, cost-effective options to alleviate neurological, diabetic, autoimmune, musculoskeletal conditions, improve aesthetics and support intelligent aging."

MSCs can be sourced from a variety of areas including Wharton’s Jelly, cord lining, and peri-vascular region of the umbilical cord. As a commonly discarded tissue, the umbilical cord contains a rich source of mesenchymal stromal cells, which are therefore obtained non-invasively.
Our MSCs are obtained by donated umbilical cords that would otherwise be disposed of. No embryonic cells are used during any point of the process.

TriCelX's proprietary state-of-the-art process is designed to ensure the fidelity of our cells in that the nMSCs are not changed or altered during processing to maintain their native architecture.
The TriCelX facility offers globally harmonized GMP-compliant cell therapy manufacturing infrastructure with controlled flow of personnel and materials and environmental monitoring, ensuring the highest level of quality control and risk mitigation for product manufacturing.

Wharton’s jelly, a gelatinous connective tissue contained in the umbilical cord. It can be used in treatments that are regulated under Section 361 of the Public Health Service Act (PHS Act) and 21 CFR Part 1271, provided it meets specific criteria related to minimal manipulation and homologous use.
TriCelX processes the tissue in a way that doesn’t fundamentally alter its original characteristics and that it’s used for the same purpose in the recipient as it was in the donor – for structural support and cushioning.
We love our customers, so feel free to visit during normal business hours.
8541 East Anderson Drive, Scottsdale, Arizona 85255, United States

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.